| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ORGN | Common Stock | Options Exercise | $61.18 | +437 | +0.36% | $0.1400 | 120,437 | 27 Jan 2023 | Direct | |
| transaction | ORGN | Common Stock | Sale | $2,622 | -437 | -0.36% | $6.00 | 120,000 | 27 Jan 2023 | Direct | F1 |
| transaction | ORGN | Common Stock | Options Exercise | $6,939 | +49,563 | +41% | $0.1400 | 169,563 | 30 Jan 2023 | Direct | |
| transaction | ORGN | Common Stock | Sale | $297,646 | -49,563 | -29% | $6.01 | 120,000 | 30 Jan 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ORGN | Stock Option (Right to Buy) | Options Exercise | $0 | -437 | -0.09% | $0.000000 | 478,682 | 27 Jan 2023 | Common Stock | 437 | $0.1400 | Direct | F3 |
| transaction | ORGN | Stock Option (Right to Buy) | Options Exercise | $0 | -49,563 | -10% | $0.000000 | 429,119 | 30 Jan 2023 | Common Stock | 49,563 | $0.1400 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Shares sold pursuant to a 10b5-1 Plan dated September 15, 2022. |
| F2 | Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.0385. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F3 | 25% of the Shares subject to the Stock Option shall vest six (6) months after September 1, 2020 (the "Vesting Commencement Date"), and 1/48 of the Shares subject to the Stock Option shall vest on each monthly anniversary of the Vesting Commencement Date thereafter. |